208 related articles for article (PubMed ID: 16043799)
1. A clinical rating scale for Batten disease: reliable and relevant for clinical trials.
Marshall FJ; de Blieck EA; Mink JW; Dure L; Adams H; Messing S; Rothberg PG; Levy E; McDonough T; DeYoung J; Wang M; Ramirez-Montealegre D; Kwon JM; Pearce DA
Neurology; 2005 Jul; 65(2):275-9. PubMed ID: 16043799
[TBL] [Abstract][Full Text] [Related]
2. The Unified Batten Disease Rating Scale (UBDRS): Validation and reliability in an independent CLN3 disease sample.
Wibbeler E; Nickel M; Schwering C; Schulz A; Mink JW
Eur J Paediatr Neurol; 2022 May; 38():62-65. PubMed ID: 35427884
[TBL] [Abstract][Full Text] [Related]
3. Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease).
Kwon JM; Adams H; Rothberg PG; Augustine EF; Marshall FJ; Deblieck EA; Vierhile A; Beck CA; Newhouse NJ; Cialone J; Levy E; Ramirez-Montealegre D; Dure LS; Rose KR; Mink JW
Neurology; 2011 Nov; 77(20):1801-7. PubMed ID: 22013180
[TBL] [Abstract][Full Text] [Related]
4. Neurological deterioration in late infantile neuronal ceroid lipofuscinosis.
Worgall S; Kekatpure MV; Heier L; Ballon D; Dyke JP; Shungu D; Mao X; Kosofsky B; Kaplitt MG; Souweidane MM; Sondhi D; Hackett NR; Hollmann C; Crystal RG
Neurology; 2007 Aug; 69(6):521-35. PubMed ID: 17679671
[TBL] [Abstract][Full Text] [Related]
5. Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates.
de Blieck EA; Augustine EF; Marshall FJ; Adams H; Cialone J; Dure L; Kwon JM; Newhouse N; Rose K; Rothberg PG; Vierhile A; Mink JW;
Contemp Clin Trials; 2013 Jul; 35(2):48-54. PubMed ID: 23628560
[TBL] [Abstract][Full Text] [Related]
6. Females experience a more severe disease course in Batten disease.
Cialone J; Adams H; Augustine EF; Marshall FJ; Kwon JM; Newhouse N; Vierhile A; Levy E; Dure LS; Rose KR; Ramirez-Montealegre D; de Blieck EA; Mink JW
J Inherit Metab Dis; 2012 May; 35(3):549-55. PubMed ID: 22167274
[TBL] [Abstract][Full Text] [Related]
7. Psychiatric symptoms of children and adolescents with juvenile neuronal ceroid lipofuscinosis.
Bäckman ML; Santavuori PR; Aberg LE; Aronen ET
J Intellect Disabil Res; 2005 Jan; 49(Pt 1):25-32. PubMed ID: 15634309
[TBL] [Abstract][Full Text] [Related]
8. Parent-reported benefits of flupirtine in juvenile neuronal ceroid lipofuscinosis (Batten disease; CLN3) are not supported by quantitative data.
Cialone J; Augustine EF; Newhouse N; Adams H; Vierhile A; Marshall FJ; de Blieck EA; Kwon J; Rothberg PG; Mink JW
J Inherit Metab Dis; 2011 Oct; 34(5):1075-81. PubMed ID: 21556831
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychological symptoms of juvenile-onset batten disease: experiences from 2 studies.
Adams HR; Kwon J; Marshall FJ; de Blieck EA; Pearce DA; Mink JW
J Child Neurol; 2007 May; 22(5):621-7. PubMed ID: 17690071
[TBL] [Abstract][Full Text] [Related]
10. Do females with juvenile ceroid lipofuscinosis (Batten disease) have a more severe disease course? The Danish experience.
Nielsen AK; Østergaard JR
Eur J Paediatr Neurol; 2013 May; 17(3):265-8. PubMed ID: 23177590
[TBL] [Abstract][Full Text] [Related]
11. Standardized assessment of seizures in patients with juvenile neuronal ceroid lipofuscinosis.
Augustine EF; Adams HR; Beck CA; Vierhile A; Kwon J; Rothberg PG; Marshall F; Block R; Dolan J; Mink JW;
Dev Med Child Neurol; 2015 Apr; 57(4):366-71. PubMed ID: 25387857
[TBL] [Abstract][Full Text] [Related]
12. Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease).
Ostergaard JR; Rasmussen TB; Mølgaard H
Neurology; 2011 Apr; 76(14):1245-51. PubMed ID: 21464428
[TBL] [Abstract][Full Text] [Related]
13. Scale for the assessment and rating of ataxia: development of a new clinical scale.
Schmitz-Hübsch T; du Montcel ST; Baliko L; Berciano J; Boesch S; Depondt C; Giunti P; Globas C; Infante J; Kang JS; Kremer B; Mariotti C; Melegh B; Pandolfo M; Rakowicz M; Ribai P; Rola R; Schöls L; Szymanski S; van de Warrenburg BP; Dürr A; Klockgether T; Fancellu R
Neurology; 2006 Jun; 66(11):1717-20. PubMed ID: 16769946
[TBL] [Abstract][Full Text] [Related]
14. Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (Batten disease).
Adams HR; Beck CA; Levy E; Jordan R; Kwon JM; Marshall FJ; Vierhile A; Augustine EF; de Blieck EA; Pearce DA; Mink JW
Dev Med Child Neurol; 2010 Jul; 52(7):637-43. PubMed ID: 20187884
[TBL] [Abstract][Full Text] [Related]
15. Remote Assessment of Cognitive Function in Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease): A Pilot Study of Feasibility and Reliability.
Ragbeer SN; Augustine EF; Mink JW; Thatcher AR; Vierhile AE; Adams HR
J Child Neurol; 2016 Mar; 31(4):481-7. PubMed ID: 26336202
[TBL] [Abstract][Full Text] [Related]
16. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype.
Kwon JM; Rothberg PG; Leman AR; Weimer JM; Mink JW; Pearce DA
Neurosci Lett; 2005 Oct; 387(2):111-4. PubMed ID: 16087292
[TBL] [Abstract][Full Text] [Related]
17. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X).
Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M
Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875
[TBL] [Abstract][Full Text] [Related]
18. Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.
Mov Disord; 1996 Mar; 11(2):136-42. PubMed ID: 8684382
[TBL] [Abstract][Full Text] [Related]
19. Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale.
Subramony SH; May W; Lynch D; Gomez C; Fischbeck K; Hallett M; Taylor P; Wilson R; Ashizawa T;
Neurology; 2005 Apr; 64(7):1261-2. PubMed ID: 15824358
[TBL] [Abstract][Full Text] [Related]
20. Unified Huntington's disease rating scale: a follow up.
Siesling S; van Vugt JP; Zwinderman KA; Kieburtz K; Roos RA
Mov Disord; 1998 Nov; 13(6):915-9. PubMed ID: 9827615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
